Starting point, intervention, evidence, and changed capability remain clear.
TRANSFORMATION / Case study / Life sciences / Developing global leadership
Leadership is a system you can build.
AstraZeneca needed leaders who could carry its shift from pharmaceutical company to science company. The answer was a maturity-led program built around the transformation itself.
PRACTICE / APPLICATION
Engagement sequence
Founder-led work in complex enterprise and institutional systems.
01
Context
02
Move
03
Consequence
The working system
The value is not the logo. It is the consequential move, the operating evidence, and the capability that remained with the people doing the work.
01
Context
Context
Support AstraZeneca’s transition from a pharmaceutical company to a science company by developing a selected India leadership cohort.
02
Move
The move
Created a transformation-specific digital maturity index and used it to shape a nine-month leadership development program.
03
Consequence
What changed
All 40 managers moved into key leadership positions across the global enterprise.
Founder-led experience
A consequential operating challenge, a deliberate move, and a result that changed what the organization could do next.
In their words
The people who vouched for the work.
“No matter what his brief was, Subbu was committed to going beyond the obvious - crafting an ambitious and compelling vision for the client or project, discovering hidden sources of strength and advantage to support it, crafting a winning position to achieve it, and driving alignment among project teams and client stakeholders around this vision.”
Siva Kumar Padmanabhan
MD and Head of Global Innovation and Technology Center, AstraZeneca India
WHAT THIS PROVES
CONTINUE THROUGH THE SYSTEM
BEGIN WITH WHAT MATTERS
Start the conversation
+
Board or executive transformation
+
NexGen GCC or human-AI capability
+
Innovation proof and commercialization
+
Role identity, work, or Data Autonomy